Norethisterone Reduces Vaginal Bleeding Caused by Progesterone-Only Birth Control Pills
Open Access
- 13 June 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (12), 3389
- https://doi.org/10.3390/jcm11123389
Abstract
(1) Background: Progesterone-only pills (POP) are widely used contraceptives. About 40% of women taking these pills report vaginal bleeding/spotting; 25% find this a reason for cessation. To date, no effective remedy has been described. We aimed to examine the therapeutic approaches offered by health providers. (2) Methods: A prospective questionnaire-based study of women experiencing vaginal bleeding due to POP, comparing the effectiveness of prescribed therapies. Women were recruited through social networks, and subsequently divided into groups according to the treatment offered: (1) POP with norethisterone (n = 36); (2) double dose POP (n = 19); (3) single dose POP (continuing initial treatment, n = 57); and (4) different POP formula (n = 8). Women rated bleeding quantity and frequency at four intervals, at weeks 0, 2, 4, and 6. (3) Results: Women who added 5 mg norethisterone acetate reported a significant decrease in bleeding frequency compared to the other groups, observed after 2, 4, and 6 weeks (p-values 0.019, 0.002, and 0.002, respectively). Women also reported an overall decrease in combined bleeding quantity and frequency (p-values 0.028, 0.003, and 0.005, respectively). There was no difference in the rate of side effects among groups. (4) Conclusions: Adding 5 mg norethisterone acetate (Primolut-nor) to progesterone-only pills significantly reduces bleeding and spotting associated with POP contraception.This publication has 24 references indexed in Scilit:
- Treatment of vaginal bleeding irregularities induced by progestin only contraceptivesPublished by Wiley ,2013
- Effect of hormonal contraceptives during breastfeeding on infant's milk ingestion and growthFertility and Sterility, 2013
- Safer prescribing of therapeutic norethisterone for women at risk of venous thromboembolismBMJ Sexual & Reproductive Health, 2012
- Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trialsContraception, 2007
- Norethisterone is bioconverted to oestrogenic compounds that activate both the oestrogen receptor α and oestrogen receptor β in vitroEuropean Journal of Pharmacology, 2002
- Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraceptionContraception, 1988
- Aromatization of norethindrone to ethynylestradiol in human adult liver.Endocrinologia Japonica, 1986
- The progestogen‐only pillBJOG: An International Journal of Obstetrics and Gynaecology, 1985
- Endometrial morphology and peripheral steroid levels in women with and without intermenstrual bleeding during contraception with the 300 μg norethisterone (NET) minipillContraception, 1982
- Order-preserving functions: Applications to majorization and order statisticsPacific Journal of Mathematics, 1967